Purchases and Sales Made in Q1 2024 in Alpine Immune Sciences, Inc. (ALPN)
This table provides information about the institutional ownership of Alpine Immune Sciences, Inc. (ALPN) during Q1 2024. The information is specifically focused on institutions that hold shares of ALPINE IMMUNE SCIENCES, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-31.1K- 38.76% |
$553K - $1.29M
|
49.2K
$0
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-42.1K- 18.0% |
$747K - $1.75M
|
192K
$0
|
|
|
May 14, 2024
Q1 2024
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-42.4K- 20.63% |
$753K - $1.77M
|
163K
$0
|
|
|
May 14, 2024
Q1 2024
|
Exodus Point Capital Management, LP
New York, NY |
SELL
|
- |
-45.8K- 21.1% |
$813K - $1.91M
|
171K
$0
|
|
|
May 15, 2024
Q1 2024
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-48.9K- 41.82% |
$867K - $2.03M
|
68K
$0
|
|
|
May 03, 2024
Q1 2024
|
Candriam S.C.A.
|
SELL
|
- |
-55K- 11.7% |
$976K - $2.29M
|
415K
$0
|
|
|
May 15, 2024
Q1 2024
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-56.5K- 32.56% |
$1M - $2.35M
|
117K
$0
|
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-65.2K- 65.05% |
$1.16M - $2.71M
|
35K
$0
|
|
|
May 13, 2024
Q1 2024
|
Eam Investors, LLC
Solana Beach, CA |
SELL
|
- |
-87.8K- 53.96% |
$1.56M - $3.65M
|
74.9K
$0
|
|
|
May 14, 2024
Q1 2024
|
Silverarc Capital Management, LLC
|
SELL
|
- |
-98.8K- 33.17% |
$1.75M - $4.11M
|
199K
$0
|
|
|
May 13, 2024
Q1 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-127K- 10.42% |
$2.26M - $5.29M
|
1.09M
$0
|
|
|
May 15, 2024
Q1 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-132K- 22.7% |
$2.35M - $5.51M
|
451K
$0
|
|
|
May 15, 2024
Q1 2024
|
Walleye Capital LLC
Plymouth, MN |
SELL
|
- |
-160K- 43.68% |
$2.84M - $6.65M
|
206K
$0
|
|
|
May 15, 2024
Q1 2024
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
SELL
|
- |
-190K- 80.91% |
$3.37M - $7.9M
|
44.8K
$0
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-226K- 46.36% |
$4.01M - $9.4M
|
261K
$0
|
|
|
May 15, 2024
Q1 2024
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-235K- 14.6% |
$4.17M - $9.78M
|
1.38M
$0
|
|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-259K- 94.71% |
$4.59M - $10.8M
|
14.4K
$0
|
|
|
Apr 22, 2024
Q1 2024
|
Vivo Capital, LLC
Palo Alto, CA |
SELL
|
- |
-299K- 36.47% |
$5.3M - $12.4M
|
521K
$0
|
|
|
May 15, 2024
Q1 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-405K- 56.62% |
$7.18M - $16.8M
|
310K
$0
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-732K- 83.68% |
$13M - $30.5M
|
143K
$0
|
|
|
May 15, 2024
Q1 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-746K- 74.57% |
$13.2M - $31M
|
254K
$0
|
|
|
May 15, 2024
Q1 2024
|
Paradigm Biocapital Advisors LP
New York, NY |
SELL
|
- |
-1.06M- 33.23% |
$18.7M - $43.9M
|
2.12M
$0
|
|
|
May 15, 2024
Q1 2024
|
Lynx1 Capital Management LP
San Juan, PR |
SELL
|
- |
-1.56M- 40.92% |
$27.7M - $64.9M
|
2.25M
$0
|
|
|
May 15, 2024
Q1 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-2.57M- 69.53% |
$45.7M - $107M
|
1.13M
$0
|